Abstract
The potential of human embryonic stem (ES) cells to meet the growing demand for cell types and tissues for the treatment of chronic and degenerative diseases has been widely acclaimed. Nevertheless, their use in cell replacement therapy poses a number of significant challenges, not least of which is their subsequent rejection by the recipient’s immune system. Here we explore the extent of the immunological barriers encountered and evaluate the potential of different approaches to overcoming these issues of which somatic nuclear transfer (SNT) and the induction of transplanation tolerance are currently the most promising.
Similar content being viewed by others
References
Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Science 1998;282:1145–1147.
Li H, Roblin G, Liu H, Heller S. Proc Natl Acad Sci USA 2003;100:13,495–13,500.
Shirahashi H, Wu J, Yamamoto N, et al. Cell Transplant 2004;13:197–211.
Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. Diabetes 2001;50:1691–1697.
Reubinoff BE, Itsykson P, Turetsky T, et al. Nat Biotechnol 2001;19:1134–1140.
Zhang S-C, Wernig M, Duncan ID, Brustle O, Thomson JA. Nat Biotechnol 2001;19:1129–1133.
Zeng X, Cai J, Chen J, et al. Stem Cells 2004;22:925–940.
Lindvall O, Kokaia Z, Martinez-Serrano A. Nat Med 2004;10:S42-S50.
Langston JW. J Clin Invest 2005;115:23–25.
Kim JH, Auerbach JM, Rodriguez-Gomez JA, et al. Nature 2002;418:50–56.
Takagi Y, Takahashi J, Saiki H, et al. J Clin Invest 2005;115:102–109.
Kehat I, Khimovich L, Caspi O, et al. Nat Biotechnol 2004;22:1282–1289.
Strom TB, Field LJ, Ruediger M. Curr Opin Immunol 2002;14:601–605.
Fairchild PJ. J Peptide Sci 1998;4:182–194.
Drukker M, Katz G, Urbach A, et al. Proc Natl Acad Sci USA 2002;99:9864–9869.
Li L, Baroja ML, Majumdar A, et al. Stem Cells 2004;22:448–456.
Banchereau J, Steinman RM. Nature 1998;392:245–252.
Lechler R, Ng WF, Steinman RM. Immunity 2001;14:357–368.
Goulmy E. Immunol Rev 1997;157:125–140.
Simpson E, Roopernian D. Curr Opin Immunol 1997;9:655–661.
Lanza RP, Cibelli JB, West MD. Nat Med 1999;5:975–977.
Mombaerts P. Proc Natl Acad Sci USA 2003;100:11,924–11,925.
Lanza RP, Chung HY, Yoo JJ, et al. Nat Biotechnol 2002;20:689–696.
Auchincloss H, Bonventre JV. Nat Biotechnol 2002;20:665–666.
Bradley JA, Bolton EM, Pedersen PA. Nat Rev Immunol 2002;2:859–871.
Fairchild PJ, Cartland S, Nolan KF, Waldmann H. Trends Immunol 2004;25:465–470.
Klug MG, Soonpaa MH, Koh GY, Field LJ. J Clin Invest 1996;98:216–224.
Li M, Pevny L, Lovell-Badge R, Smith A. Curr Biol 1998;8:971–974.
Lechler RI, Batchelor JR. J Exp Med 1982;155:31–41.
Waldmann H, Cobbold SP. Immunity 2001;14:399–406.
Wood KJ, Sakaguchi S. Nat Rev Immunol 2003;3:199–210.
Chen T-C, Cobbold SP, Fairchild PJ, Waldmann H. J Immunol 2004;172:5900–5907.
Chen T-C, Waldmann H, Fairchild PJ. J Clin Invest 2004;113:1754–1762.
Jonuleit H, Schmitt E, Schuler G, Knop J, Enk EH. J Exp Med 2000;192:1213–1222.
Roncarolo M-G, Levings MK, Traversari C. J Exp Med 2001;193:F5-F9.
Zheng XX, Sanchez-Fueyo A, Sho M, Domenig C, Sayegh MH, Strom TB. Immunity 2003;19:503–514.
Lechler RI, Garden OA, Turka LA. Nat Rev Immunol 2003;3:147–158.
Eiges R, Schuldiner M, Drukker M, Yanuka O, Itskovitz-Eldor J, Benvenisty N. Curr Biol 2001;11:514–518.
Park S, Kim EY, Ghil GS, et al. Neurosci Lett 2003;353:91–94.
Matin MM, Walsh JR, Gokhale PJ, et al. Stem Cells 2004;22:659–668.
Zwaka TP, Thomson JA. Nat Biotechnol 2003;21:319–321.
Streilein JW. Nat Rev Immunol 2003;3:879–889.
Erlebacher A. Curr Opin Immunol 2001;13:590–593.
Mellor AL, Munn DH. Trends Immunol 1999;20:469–473.
Munn DH, Zhou M, Attwood JT, et al. Science 1998;281:1191–1193.
Schepers K, Schumacher TMN. Nat Med 2003;9:1253–1254.
Uyttenhove C, Pilotte L, Theate I, et al. Nat Med 2003;9:1269–1274.
Gabrilovich D. Nat Rev Immunol 2004;4:941–952.
Curiel TJ, Coukos G, Zou L, et al. Nat Med 2004;10:942–949.
Alexander AM, Crawford M, Bertera S, et al. Diabetes 2002;51:356–365.
Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA. Proc Natl Acad Sci USA 2001;98:10,716–10,721.
Sykes M. Immunity 2001;14:417–424.
Burt RK, Verda L, Kim D-A, Oyama Y, Luo K, Link C. J Exp Med 2004;199:895–904.
Moustafa ME, Srivastava AS, Nedelcu E, et al. Transplantation 2004;78:1274–1284.
Fändrich F, Lin X, Chai GX, et al. Nat Med 2002;8:171–178.
Rathjen J, Rathjen PD. Curr Opin Genet Dev 2001;11:587–594.
Qin S, Cobbold SP, Pope H, et al. Science 1993;259:974–977.
Fairchild PJ, Waldmann H. Curr Opin Immunol 2000;12:528–535.
Hawiger D, Inaba K, Dorsett Y, et al. J Exp Med 2001;194:769–779.
Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. J Exp Med 2002;196:1627–1638.
Mahnke K, Qian Y, Knop J, Enk AH. Blood 2003;101:4862–4869.
Dhodapkar MW, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. J Exp Med 2001;193:233–238.
Fairchild PJ, Brook FA, Gardner RL, et al. Curr Biol 2000;10:1515–1518.
Fairchild PJ, Nolan KF, Waldmann H. Methods Enzymol 2003;365:169–186.
Fairchild PJ, Nolan KF, Graça L, Waldmann H. Transplantation 2003;76:606–608.
Fairchild PJ, Nolan KF, Cartland S, Waldmann H. Int Immunopharmacol 2004;5:13–21.
De Smedt T, Van Mechelen M, De Becker G, Urbain J, Leo O, Moser M. Eur J Immunol 1997;27:1229–1235.
Penna G, Adorini L. J Immunol 2000;164:2405–2411.
Gregori S, Castorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. J Immunol 2001;167:1945–1953.
Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Blood 2003;102:3980–3988.
Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. Annu Rev Immunol 2004;22:307–328.
Hochweller K, Anderton SM. Eur J Immunol 2004;34:990–998.
Martin E, O’Sullivan B, Low P, Thomas R. Immunity 2003;18:155–167.
Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM. J Exp Med 2004;199:1607–1618.
Tone M, Tone Y, Fairchild PJ, Wykes M, Waldmann H. Proc Natl Acad Sci USA 2001;98:1751–1756.
Ferguson TA, Herndon J, Elzey B, Griffith TS, Schoenberger S, Green DR. J Immunol 2002;168:5589–5595.
Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. J Exp Med 2002;196:1091–1097.
Quezada SA, Fuller B, Jarvinen LZ, et al. Blood 2003;102:1920–1926.
Mirenda V, Berton I, Read J, et al. J Am Soc Nephrol 2004;15:987–997.
Zhan X, Dravid G, Ye Z, et al. Lancet 2004;364:163–171.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fairchild, P.J., Robertson, N.J., Cartland, S. et al. Cell replacement therapy and the evasion of destructive immunity. Stem Cell Rev 1, 159–167 (2005). https://doi.org/10.1385/SCR:1:2:159
Issue Date:
DOI: https://doi.org/10.1385/SCR:1:2:159